
Mark L. Berch
Examiner (ID: 2144)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 2899, 1802, 1202, 1611, 1622, 1624, 1614 |
| Total Applications | 3573 |
| Issued Applications | 2301 |
| Pending Applications | 170 |
| Abandoned Applications | 1103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6628790
[patent_doc_number] => 20100004236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'PHOSPHODIESTERASE 4 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/393634
[patent_app_country] => US
[patent_app_date] => 2009-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26063
[patent_no_of_claims] => 97
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20100004236.pdf
[firstpage_image] =>[orig_patent_app_number] => 12393634
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/393634 | PHOSPHODIESTERASE 4 INHIBITORS | Feb 25, 2009 | Abandoned |
Array
(
[id] => 5532980
[patent_doc_number] => 20090232768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'NOVEL COMPOUNDS AND METHODS FOR THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/388789
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24980
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232768.pdf
[firstpage_image] =>[orig_patent_app_number] => 12388789
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/388789 | Nucleoside analogues containing phosphonate or phosphonamide groups | Feb 18, 2009 | Issued |
Array
(
[id] => 5422945
[patent_doc_number] => 20090149400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'ANTI-PROLIFERATIVE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/388295
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34441
[patent_no_of_claims] => 130
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149400.pdf
[firstpage_image] =>[orig_patent_app_number] => 12388295
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/388295 | Anti-proliferative compounds, compositions, and methods of use thereof | Feb 17, 2009 | Issued |
Array
(
[id] => 8802544
[patent_doc_number] => 08440819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-14
[patent_title] => 'Therapeutic substituted beta-lactams'
[patent_app_type] => utility
[patent_app_number] => 12/372417
[patent_app_country] => US
[patent_app_date] => 2009-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7232
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12372417
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/372417 | Therapeutic substituted beta-lactams | Feb 16, 2009 | Issued |
Array
(
[id] => 5540016
[patent_doc_number] => 20090221821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'ADENOSINE RECEPTOR ANTAGONISTS AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/368469
[patent_app_country] => US
[patent_app_date] => 2009-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 36760
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221821.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368469
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368469 | ADENOSINE RECEPTOR ANTAGONISTS AND METHODS OF MAKING AND USING THE SAME | Feb 9, 2009 | Abandoned |
Array
(
[id] => 5380337
[patent_doc_number] => 20090192176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => '1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES'
[patent_app_type] => utility
[patent_app_number] => 12/361607
[patent_app_country] => US
[patent_app_date] => 2009-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50223
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192176.pdf
[firstpage_image] =>[orig_patent_app_number] => 12361607
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/361607 | 1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES | Jan 28, 2009 | Abandoned |
Array
(
[id] => 5575989
[patent_doc_number] => 20090143351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'SUBSTITUTED AZETIDINONES'
[patent_app_type] => utility
[patent_app_number] => 12/359490
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 136
[patent_figures_cnt] => 136
[patent_no_of_words] => 39616
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143351.pdf
[firstpage_image] =>[orig_patent_app_number] => 12359490
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/359490 | SUBSTITUTED AZETIDINONES | Jan 25, 2009 | Abandoned |
Array
(
[id] => 5279300
[patent_doc_number] => 20090131432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'XANTHINE DERIVATES, THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/355011
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11526
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131432.pdf
[firstpage_image] =>[orig_patent_app_number] => 12355011
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/355011 | Xanthine derivates, their preparation and their use in pharmaceutical compositions | Jan 15, 2009 | Issued |
Array
(
[id] => 7550700
[patent_doc_number] => 08063033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => 'Therapeutic beta-lactams'
[patent_app_type] => utility
[patent_app_number] => 12/352903
[patent_app_country] => US
[patent_app_date] => 2009-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10373
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/063/08063033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12352903
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/352903 | Therapeutic beta-lactams | Jan 12, 2009 | Issued |
Array
(
[id] => 7535383
[patent_doc_number] => 08049009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Process for the preparation of Tenofovir'
[patent_app_type] => utility
[patent_app_number] => 12/352182
[patent_app_country] => US
[patent_app_date] => 2009-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3474
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/049/08049009.pdf
[firstpage_image] =>[orig_patent_app_number] => 12352182
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/352182 | Process for the preparation of Tenofovir | Jan 11, 2009 | Issued |
Array
(
[id] => 4540015
[patent_doc_number] => 07875608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-25
[patent_title] => 'Substituted 8-[6-amino-3pyridyl]xanthines'
[patent_app_type] => utility
[patent_app_number] => 12/337010
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7783
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/875/07875608.pdf
[firstpage_image] =>[orig_patent_app_number] => 12337010
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/337010 | Substituted 8-[6-amino-3pyridyl]xanthines | Dec 16, 2008 | Issued |
Array
(
[id] => 5546721
[patent_doc_number] => 20090156598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Imidazolopyrimidine modulators of TRPV1'
[patent_app_type] => utility
[patent_app_number] => 12/316827
[patent_app_country] => US
[patent_app_date] => 2008-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11146
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156598.pdf
[firstpage_image] =>[orig_patent_app_number] => 12316827
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/316827 | Imidazolopyrimidine modulators of TRPV1 | Dec 15, 2008 | Abandoned |
Array
(
[id] => 8245064
[patent_doc_number] => 08202991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Process for the preparation of 2-fluoroadenine'
[patent_app_type] => utility
[patent_app_number] => 12/332723
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2533
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202991.pdf
[firstpage_image] =>[orig_patent_app_number] => 12332723
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/332723 | Process for the preparation of 2-fluoroadenine | Dec 10, 2008 | Issued |
Array
(
[id] => 5441818
[patent_doc_number] => 20090093457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/331720
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21053
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093457.pdf
[firstpage_image] =>[orig_patent_app_number] => 12331720
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/331720 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | Dec 9, 2008 | Issued |
Array
(
[id] => 7687308
[patent_doc_number] => 20090176983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal'
[patent_app_type] => utility
[patent_app_number] => 12/325525
[patent_app_country] => US
[patent_app_date] => 2008-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12512
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176983.pdf
[firstpage_image] =>[orig_patent_app_number] => 12325525
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/325525 | Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal | Nov 30, 2008 | Abandoned |
Array
(
[id] => 6002955
[patent_doc_number] => 20110118229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => '2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/742966
[patent_app_country] => US
[patent_app_date] => 2008-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13226
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118229.pdf
[firstpage_image] =>[orig_patent_app_number] => 12742966
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742966 | 2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Nov 17, 2008 | Abandoned |
Array
(
[id] => 5272494
[patent_doc_number] => 20090076270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Drying process for preparing crystalline solid famciclovir'
[patent_app_type] => utility
[patent_app_number] => 12/291951
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3559
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076270.pdf
[firstpage_image] =>[orig_patent_app_number] => 12291951
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/291951 | Drying process for preparing crystalline solid famciclovir | Nov 13, 2008 | Abandoned |
Array
(
[id] => 4624340
[patent_doc_number] => 08003636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Certain crystalline diphenylazetidinone hydrates, pharmaceutical compositions thereof and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 12/269802
[patent_app_country] => US
[patent_app_date] => 2008-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11098
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003636.pdf
[firstpage_image] =>[orig_patent_app_number] => 12269802
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/269802 | Certain crystalline diphenylazetidinone hydrates, pharmaceutical compositions thereof and methods for their use | Nov 11, 2008 | Issued |
Array
(
[id] => 5316477
[patent_doc_number] => 20090281075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/267271
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19229
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20090281075.pdf
[firstpage_image] =>[orig_patent_app_number] => 12267271
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/267271 | ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS | Nov 6, 2008 | Abandoned |
Array
(
[id] => 5304405
[patent_doc_number] => 20090299057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'MEROPENEM INTERMEDIATE IN NOVEL CRYSTALLINE FORM AND A METHOD OF MANUFACTURE OF MEROPENEM'
[patent_app_type] => utility
[patent_app_number] => 12/255668
[patent_app_country] => US
[patent_app_date] => 2008-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3528
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20090299057.pdf
[firstpage_image] =>[orig_patent_app_number] => 12255668
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/255668 | Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem | Oct 21, 2008 | Issued |